Clinical trial

Paliperidone Extended Release in Schizophrenia Participants With Duration of Illness Less Than 10 Years

NCT01362439

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-01-01

PhasePHASE4

Study timeline

Study start (unknown)2009-01-01Date precision: month

Registry last updated2013-06-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

Paliperidone ERDRUG

Sponsors & collaborators

Janssen-Cilag S.p.A.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01362439 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.